Seeds Capital is an investment entity that provides early-stage funding for innovative startups in Singapore. It operates under the purview of Enterprise Singapore, the government agency responsible for developing the nation's enterprise ecosystem. Seeds Capital aims to nurture startups by providing not just capital but also strategic guidance and connections to industry networks.

Seeds Capital

As the investment arm of Enterprise Singapore, SEEDS Capital catalyses smart monies into Singapore-based early-stage technology startups. We co-invest with institutional investors in innovative startups with strong intellectual content and global market potential.  

We focus on nascent and strategic industries such as Advanced Manufacturing & Engineering, Health & Biomedical Sciences and Urban Solutions & Sustainability. We also look at other emerging technologies such as Agri-tech, Artificial Intelligence, Blockchain, Quantum Computing and Space Technologies.  

Post-investment, we leverage Enterprise Singapore’s networks across industries and global overseas centres to support the growth of our portfolio companies. Today, we have over 100 startups in our portfolio and we work with more than 40 co-investment partners.

SEEDS Capital

Congratulations to our investee VFlowTech for raising US$10 million in their recent Series A fundraising round! 🎉
 
Led and co-invested with appointed partner Real Tech Holdings Co.,Ltd., we participated in the funding round alongside other investors such as Wavemaker Partners, Pappas Capital, Sing Fuels, Inci Holdings, Michael Gryseels and Carbon Zero Venture Capital. 
 
Founded in 2018, VFlowTech is a #batterytech startup that has developed a vanadium-based redox flow battery for sustainable, renewable energy storage. As part of this funding round, VFlowTech plans to set up a 200MWh production line capacity and scale up the manufacturing of its 250kWh modular vanadium-based long-duration energy storage solutions. In addition, it also plans to expand into the USA, Japan, Turkey and India while enhancing its product capabilities through R&D. 
 
As one of SEEDS Capital’s first investments into storage solutions for #renewableenergy, we are happy to witness VFlowTech's growth, alongside Enterprise Singapore. We believe that its technology will tackle renewable energy needs in Singapore and beyond, as a viable solution to address the intermittency of #renewables. 🔋🔋🔋
 
Looking forward to continue supporting the company in its next phase of growth. Congratulations to Avishek Kumar and team! 
 
Read more: https://lnkd.in/gp2gBJZb 
 
#CleanEnergy #Sustainability #deeptech #innovation #venturecapital

We’re happy to have participated in our investee ION Mobility’s latest US$18.7 million Series A fundraise alongside co-investor TNB AURA, in a round led by TVS Motor Company! 🎉
 
With a mission to create affordable, desirable and sustainable mobility solutions, ION Mobility is building the leading electric vehicle (#EV) motorcycle business in Southeast Asia. This funding round will accelerate the company’s business growth, as it looks to boost local presence and manufacturing capabilities in Indonesia. Having recently launched its M1–S electric scooter in Jakarta, ION Mobility has also signed a partnership MOU with Indonesia’s national grid operator, PLN, to expand its local charging network. 
 
Moving forward, ION Mobility will be able to tap lead investor TVS Motor Company’s resources and know-how as one of the world’s largest motorcycle manufacturers, and drive further success in the electric two-wheeler market within the region. 🏍
 
Together with Enterprise Singapore, we are happy to support and witness ION Mobility’s growth over the past few years, and we look forward to more exciting developments in the coming years ahead. 
 
Congrats to James Chan and team! 
 
Read more: https://lnkd.in/gK4aNtZm
 
#deeptech #venturecapital #electricmotorcycle #electricvehicles

Our heartiest congratulations to investee AiDA Technologies Pte Ltd, a leading #AI #insurtech startup in Singapore, for a successful acquisition to Amplify Health. 
 
Founded in 2016, AiDA has developed proprietary #machinelearning models to provide predictive analytics for insurers and enable faster, more efficient and accurate processing of claims. Since our investment in 2021 alongside co-investor Kuok Ventures under the Special Situation Funds for Startups (SSFS) scheme, AiDA has managed to grow significantly, notably clinching contracts with major industry players such as AIA, Singlife, Aviva, Ascension and GREAT EASTERN. Besides securing key partnerships, AiDA also received validation for its tech from industry peers, being one of the finalists of the 2021 Global Fast Track #InsurTech competition. 

This acquisition will bolster Amplify Health’s data capabilities through the addition of highly skilled data scientists from AiDA tech, and also enable Amplify Health to tap on AiDA’s established client base across Southeast Asia. With good synergies between both companies, we are excited to witness AiDA join forces with Amplify Health to spur innovation within the #InsurTech space.
 
Along with Enterprise Singapore, we are happy to have supported AiDA’s growth journey thus far and would like to congratulate the team once again for the successful acquisition! 
 
Read more here: https://lnkd.in/gBwNB5vf
 
#deeptech #innovation #venturecapital #MergersandAcqusitions #datascience

We’re excited to announce a new addition to our portfolio! Qritive, a leading healthcare #AI startup, recently raised a S$7.5 million Series A led by our co-investment partner MassMutual Ventures, with participation from Exfinity Venture Partners.
 
Qritive provides fast and accurate interpretations of #pathology image scans within seconds, reducing time to treatment and increasing accuracy for #cancer care. Through its innovative solution, Qritive hopes to digitise and streamline end-to-end pathology workflows and accelerate adoption of #digitalpathology to improving patient outcomes around the world. 
 
As part of this fundraise, Qritive aims to expand its geographical presence, increase its product portfolio, and support regulatory clearance.  
 
We’re happy to have participated in Qritive’s Series A round, and along with Enterprise Singapore, we look forward to support the company’s growth going forward. 
 
Congrats to Aneesh Sathe, Ph.D., Kaveh Taghipour and the team at Qritive! 
 
Read more: https://lnkd.in/e8FntJwn
 
#deeptech #venturecapital #innovation #oncology #cancerdiagnostics

Alongside our co-investor The Yield Lab Asia Pacific, we recently participated in the follow-on investment into homegrown #agritech startup, Protenga, in a round which includes JBI Innovations. 
 
Protenga has developed a proprietary, scalable and vertically integrated #SmartInsectFarming platform that uses palm waste to generate pet food and aquaculture products. Notably, Protenga recently launched its wet pet food product portfolio, making it the first and only company globally to produce wet dog food with fresh insect proteins. Funds raised from this round will be used to support the production of its second generation Smart Insect Farm in early 2023. 
 
With a clear vision of achieving #sustainability through upcycling palm by-products, we look forward to Protenga’s next stage of commercial growth and expansion across key markets such as #Indonesia and #Malaysia, alongside Enterprise Singapore.  
 
Congrats to the Protenga team! 
 
Read more here: https://lnkd.in/greVne8i
 
#deeptech #innovation #venturecapital #blacksoldierfly #insectfarming

We’re delighted to welcome AlterPacks into our portfolio, after their recent successful US$1 million pre-seed funding round! The #Singapore-based new material #technology startup’s latest funding round saw participation from co-investor Plug and Play Tech Center, Earth Venture Capital and angel investor Alice Foo. 
 
Founded in 2019, #Alterpacks upcycles food disposed by manufacturers to create a biodegradable and home-compostable material that effectively replaces plastic food containers. Commercial production of its containers has already begun, and funds raised will go towards accelerating production and overseas expansion across key markets in Asia, Australia and Europe.  
 
We are happy to have participated in the funding round and with Enterprise Singapore, we look forward to supporting Alterpack’s mission to create a more sustainable future by tackling food waste and reducing the use of single-use plastics. 
 
Congrats to the Alterpacks team! 
 
Read more: https://lnkd.in/gUXzyNEr 
 
#deeptech #innovation #venturecapital #sustainability #foodwaste #materialsscience #packaging

With 2022 in the books, we are happy to be named by Tech in Asia as the most active startup investor in Singapore the past year, alongside many of our co-investment partners.  
 
Our Quarterly Investment Round-Up for Q4 2022 is added testament to our investment activity, as we continue to witness sustained funding growth into #deeptech startups.
 
We’d like to welcome the following startups into our portfolio (left), along with our co-investors (right): 
🎉 Aktivolabs – Adaptive Capital Partners
🎉 AlterPacks – Plug and Play Tech Center 
🎉 KYAN Therapeutics – Altara Ventures 
🎉 Polybee – elev8.vc  
 
These are several follow-on investments we made this quarter, given strong traction and growth from our investees: 
🎉 ABM Respiratory Care – MedTech Alliance II (Advanced MedTech) 
🎉 Aevice Health – Silicon Solution Partners
🎉 ceEntek Pte Ltd – Real Tech Holdings Co.,Ltd. 
🎉 Popsical – Quest Ventures 
 
Congratulations to all the startups. We are excited to support more innovative, high-growth #deeptech Singapore startups in 2023! 
 
Read more here: https://lnkd.in/gZ4uKXsH
 
#innovation #venturecapital #advancedmanufacturingengineering #healthbiomedicalsciences #urbansolutionssustainability

Our heartfelt congratulations to the Alchemy Foodtech | Alchemy Fibre™team for recently closing an oversubscribed US$3 million round from investors, including Thai President Foods Public Company Limited, Pine Venture Partners, and Selera Kapital. Besides our co-investment with Heritas Capital, other existing investors that followed on includes global seafood leader Thai Union Group PCL. and Fuchsia Venture Capital. 
 
The Singapore-based #FoodTech startup has developed its patented Alchemy Fibre tech platform, with an aim to #MakeCarbsGood by reducing carbohydrates, sugar and glycemic index (GI) in foods, while delivering great taste and texture to consumers. Since our last investment, Alchemy Foodtech has continued to make tremendous commercial progress, working with corporates such as Swee Heng, Boon Tong Kee, and Yum Cha to incorporate its Alchemy Fibre into various products. Furthermore, it has also launched its flagship product, Alchemy Fibre for Rice, in supermarkets and e-commerce platforms regionally. 
 
We look forward to Alchemy’s upcoming collaborations and new product launches in 2023 and are delighted to have witnessed Alchemy’s growth in the past year. Along with Enterprise Singapore, we will continue supporting the company as it expands its regional footprint beyond Singapore. 
 
Congratulations to the team once again! 
 
Read more: https://lnkd.in/gXqpWspp 
 
#deeptech #innovation #venturecapital

A warm welcome to Aktivolabs, who recently joined our portfolio as part of its US$10 million Series A fundraise, led by Mitsui & Co., Ltd. and with co-investment from Adaptive Capital Partners.  
 
Founded in 2017, the digital healthtech startup has developed an innovative tech solution that uses real-time data of users and proprietary algorithm to generate a digital biomarker for health and longevity, known as the Aktivo Score®. Aimed to predict and prevent chronic diseases, this data provides measurable actuarial and actionable value for life and health insurers, in a low-touch, cost-effective manner. 

As part of this fundraise, Aktivolabs aims to grow its data science capability, strengthen its existing team,expand its portfolio of products (eg. Aktivo® Mind, Glucolife and Goodbiome), and broaden its global footprint. 
 
Congratulations to the team and along with Enterprise Singapore, we look forward to supporting Aktivolabs in the coming years ahead. 
 
Read more here: https://lnkd.in/gEdq65t5
 
#digitalhealth #healthtech #insurtech #venturecapital #deeptech #funding

As healthcare continue to become an increasing priority for investors and many governments globally, from tackling aging population with increased medical needs to driving affordable healthcare for the masses, many investors are placing their bets on Singapore-grown startups that can serve these needs and foster innovation in a sector primed for growth in the next 3-5 years. 
 
In this interview with South China Morning Post SCMP, our co-investment partners shared about the evolution of Singapore’s #healthbiomed ecosystem, the opportunities that can be captured going forward, as well as the relevant tools and resources in Singapore that investors can tap on to derisk their investments into early-stage deep-tech startups (that has the potential to generate positive impact for society) -- including co-investments with SEEDS Capital. 
 
We are thankful for the contribution of our co-investors in growing the local #deeptech #healthbiomed startups and offering their time to share about their experience in this interview. 

Looking forward to doing more in the coming years ahead! 
Wai Chiew CHIK - Heritas Capital 
Kok Hwee Sim - ZICOM Holdings Private Limited
Eric Chee Mun Loh, CFA - Trendlines Medical Singapore 
Abel Ang - Advanced MedTech Group/ MedTech Alliance II 
 
Read more here: https://lnkd.in/egpnqWjt 

#venturecapital #innovation #healthcare #biotech #medtech #digitalhealth

Metric
Company Name	Seeds Capital
Symbol
MSH ID	SG:SEEDSCAPITAL
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Venture Capital & Private Equity
Country	SG
Stage
Employee Count	19
Website	seedscapital.sg
LinkedIn	seedscapitalsg
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

SG:SEEDSCAPITAL

Seeds Capital

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue